Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISCT 2020 | ISCT demands proper clinical investigation for COVID-19 therapies

John Rasko • 28 May 2020
ISCT 2020
General

John Rasko, BSc(Med), MBBS(Hons), PhD, MAICD, FFSc(RCPA), FRCPA, FRACP, FAHMS, The University of Sydney, Centenary Institute and Royal Prince Alfred Hospital, NSW, Australia, discusses the recent publications from the International Society of Cellular Therapy (ISCT) on therapies for COVID-19 and the need for proper clinical investigations. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from John Rasko

2:54
Looking forward to ISCT
John Rasko • 28 May 2020

Related Videos

0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:44
PHOEBUS trial: oral fecal microbiotherapy for increasing OS in patients undergoing alloSCT
Florent Malard • 11 Apr 2024
2:24
Manipulating the gut microbiome to improve outcomes of alloSCT for hematological malignancies
Florent Malard • 11 Apr 2024
3:29
PTCy as GvHD prophylaxis: side effects, optimizing the dose, and the effect of dose-reduction
Rémy Duléry • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals